zoledronic acid has been researched along with deoxypyridinoline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siris, E | 1 |
| Baccarani, M; Boni, P; Cangini, D; Cavo, M; Ceccolini, M; Cellini, C; Parente, R; Perrone, G; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E | 1 |
| Açil, Y; Behrens, C; Gassling, V; Gierloff, M; Möller, B; Niehoff, P; Simon, M; Wiltfang, J | 1 |
| Hahn, NM; Kirkpatrick, K; Sharma, J; Sweeney, CJ; Yiannoutsos, CT | 1 |
| Baykan, EK; Cetinkalp, S; Erdogan, M; Ozgen, AG; Saygılı, LF; Yilmaz, C | 1 |
| Açil, Y; Gierloff, M; Gülses, A; Niehoff, P; Reutemann, M; Wiltfang, J | 1 |
| Liel, Y; Plakht, Y; Tailakh, MA | 1 |
3 trial(s) available for zoledronic acid and deoxypyridinoline
| Article | Year |
|---|---|
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Collagen Type I; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Pain; Peptides; Thalidomide; Treatment Outcome; Zoledronic Acid | 2006 |
Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Diphosphonates; Disease Progression; Disease-Free Survival; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Osteocalcin; Pamidronate; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Zoledronic Acid | 2014 |
Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial.
Topics: Aged; Aged, 80 and over; Amino Acids; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Chromatography, High Pressure Liquid; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Radiation Injuries; Radiotherapy; Zoledronic Acid | 2015 |
4 other study(ies) available for zoledronic acid and deoxypyridinoline
| Article | Year |
|---|---|
Zoledronate in the treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Bone and Bones; Clinical Trials as Topic; Creatine; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Imidazoles; Male; Osteitis Deformans; Zoledronic Acid | 1996 |
Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline.
Topics: Amino Acids; Animals; Bone and Bones; Bone Density Conservation Agents; Chromatography, High Pressure Liquid; Collagen Type I; Collagen Type V; Diphosphonates; Electrophoresis, Polyacrylamide Gel; Hydroxyproline; Imidazoles; Male; Rats; Rats, Wistar; Zoledronic Acid | 2013 |
Efficacy of zoledronic acid treatment in Paget disease of bone.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density Conservation Agents; Diphosphonates; Drug Evaluation; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Remission Induction; Retrospective Studies; Treatment Outcome; Zoledronic Acid | 2014 |
BONE TURNOVER IN OSTEOPOROTIC WOMEN DURING LONG-TERM ORAL BISPHOSPHONATES TREATMENT: IMPLICATIONS FOR TREATMENT FAILURE AND "DRUG HOLIDAY" IN THE REAL WORLD.
Topics: Administration, Intravenous; Administration, Oral; Aged; Alendronate; Amino Acids; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Deprescriptions; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Risedronic Acid; Time Factors; Treatment Failure; Zoledronic Acid | 2017 |